Active Implants Receives FDA Breakthrough Device Designation for NUsurface Meniscus Implant

Active Implants was granted a Breakthrough Device Designation from FDA for the NUsurface® Meniscus Implant. If cleared by FDA, NUsurface would be the first artificial meniscus in the U.S. market.

The Orthopaedic Implant Company in Pilot Program to Lower Supply Costs

The Orthopaedic Implant Company is participating in a pilot program which has led to a $3.6MM reduction in supply expenses for one integrated delivery network. 

OrthoSpin Gains FDA Clearance for Robotic ExFix System

OrthoSpin received FDA 510(k) clearance to market its smart robotic external fixator.